VISION-DMD

Designed to ensure a timely & cost-effective drug development for Duchenne muscular dystrophy

Search

  • The Project
    • Summary
    • Project Objectives
    • Project Consortium
    • Contact us
  • About DMD
    • What is DMD?
    • Living with Duchenne
    • Current treatment options
    • Duchenne boy’s stories
    • DMD Community
    • Standards of Care for Duchenne muscular dystrophy
  • Study Information
    • What is a clinical study?
    • Phase 2a clinical trial information
    • Phase 2a preliminary study results
    • Phase 2b clinical trial information
    • Phase 2b Preliminary Results
    • MRI – Magnetic Resonance Imaging
  • Drug Development
    • Development of Vamorolone
    • Vamorolone development programme
  • Innovations
    • Return of patient data
    • Bone Health Outcomes
    • Biomarkers
    • Vamorolone study APP for boys
    • Patient Group Funders
    • What is Venture Philanthropy?
  • Resources
    • Relevant publications
      • VISION-DMD INFORMATION APP OVERVIEW
      • VISION-DMD Thought paper
    • VISION-DMD Workshops
      • Workshop series: Standards of Care
      • Workshop series: Biomarkers and Imaging
    • Webinars and presentations
    • Press Releases
    • VISION-DMD project Interviews
      • Collaborating for progress on rare diseases: an interview with Dr. Daria Julkowska, Scientific Coordinator of the European Joint Program on Rare Diseases.
      • Returning vamorolone study data to patient caregivers. What, when and how clinical trial data is returned to study participants. An interview with Dr. Laurie Conklin
      • An Interview with Andrea D’Alessandro – Clinical research project manager at TRiNDS
      • Interview with Jana Haberlová – Paediatric Neurologist at University Hospital Motol
      • Interview with Alex Johnson: a parent and patient foundation funder
    • VISION-DMD Project Newsletters
      • VISION-DMD newsletter sign up
    • VISION-DMD Poster presentations
    • Our privacy policy
  • English
    • Nederlands
    • Français
    • Deutsch
    • Italiano
    • Español

DMD Community

World Duchenne Awareness Day

The first World Duchenne Awareness Day  (WDAD) took place on 7th September 2014 and is an international event whose main goal is to raise awareness of Duchenne muscular dystrophy and the importance of early diagnosis and daily therapy.

In 2019 Bring your light to the world for World Duchenne Awareness Day!

Click here for more information on WDAD

Previous events

 

 

World Duchenne Awareness Day  represents a great action of the global Duchenne Community to raise awareness for children and young adults living with Duchenne Muscular Dystrophy.

This initiative is, year after year, becoming so impactful involving more than 40 countries, around 70 organizations and for the second year is celebrated under the High Patronage of The European Parliament. Having Pope Francis acknowledge WDAD to make it more powerful. WDAD 2016 will be focused on Early Diagnosis: identifying and communicating early signs of Duchenne in order to guarantee a good quality of life to the children. Although some studies show a slight improvement in the age of diagnosis of Duchenne there continues to be a delay on average of around 2 years in terms of diagnosing through a health professional and in obtaining a CK test after parents have seen the first signs. To reduce these delays, neonatal screening for Duchenne is instrumental but so far it is only available in a few countries. Early recognition of the obvious signs is the best instrument we have at the moment. Delayed gross motor milestones, Gower’s sign, and delayed speech should raise a red flag and be followed up by a CK blood test as soon as possible. Early diagnosis of Duchenne will allow for timely access to genetic counseling, standards of care, and opportunities for clinical trials.

Through video’s the world will be informed about the Early Signs of Duchenne Muscular Dystrophy and the importance of Early Diagnosis.

The global activities are shared on the World Duchenne Awareness Day Facebook page. WDAD is also on Twitter and Instagram.

World Duchenne Awareness Day is initiated by United Parent Projects Muscular Dystrophy and made possible by the Duchenne community worldwide. All materials are made by parents, neighbors, friends.

Follow us on twitter

  • Twitter

EUFlag2020

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement number 667078.

To find out more about the project contact us at [email protected]

VISION-DMD Copyright © 2023 · Log in

Multilingual WordPress with WPML